The effect of low-dose simvastatin in children with familial hypercholesterolaemia: A 1-year observation

European Journal of Pediatrics

Volumn 162, Issue 6, 2003, Pages 421-425

  Dirisamer, Albert ^a   Hachemian, Nilouparak ^a   Bucek, Robert Alexander ^b   Wolf, Florian ^a   Reiter, Markus ^b   Widhalm, Kurt ^a  

^a UNIVERSITY OF VIENNA   (Austria)

^b KRANKENANSTALT RUDOLFSTIFTUNG   (Austria)

Author keywords

Children; Familial hypercholesterolaemia; HMG CoA reductase inhibitor; Simvastatin

Indexed keywords

HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; LOW DENSITY LIPOPROTEIN CHOLESTEROL; SIMVASTATIN;

ABDOMINAL PAIN; ADOLESCENT; ARTICLE; ATHEROSCLEROSIS; CARDIOVASCULAR DISEASE; CHILD; CLINICAL ARTICLE; CLINICAL TRIAL; DIARRHEA; DRUG EFFECT; DRUG EFFICACY; DRUG SAFETY; FAMILIAL HYPERCHOLESTEROLEMIA; FATIGUE; FEMALE; GASTROINTESTINAL SYMPTOM; HEADACHE; HUMAN; INSOMNIA; LIPID METABOLISM; LOW DRUG DOSE; MALE; MYALGIA; PRIORITY JOURNAL; RASH; RISK FACTOR; SIDE EFFECT;

EID: 0038620262     PISSN: 03406199     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00431-003-1181-3     Document Type: Article

References (20)

1. Barth JA, Deckelbaum J, Starc TJ, Shea S, Mosca L, Berglund L (1999) Family history of early cardiovascular disease in children with moderate to severe hypercholesterolemia: relationship to lipoprotein(a) and low-density lipoprotein cholesterol levels. J Lab Clin Med 133: 237-244
2. Berenson GS, Srinivasan SR, Bao W, Newman WP, Tracy RE, Wattigney WA (1998) Association between multiple risk factors and atherosclerosis in children and young adults. N Engl J Med 338: 1650-1656
3. Couture P, Brun LD, Szots F, Lelievre M, Gaudet D, Despres JP, Simard J, Lupien PJ, Gagne C (1998) Association of specific LDL receptor mutations with differential plasma lipoprotein response to Simvastatin in young french canadians with heterozygous familial hypercholesterolemia. Arterioscler Thromb Vasc Biol 18: 1007-1012
4. Ducobu J, Brasseur D, Chaudron JM, Deslypere JP, Harvengt C, Muls E, Thomson M (1992) Simvastatin use in children. Lancet 339: 1488
5. Friedewald WT, Levy RI, Fredrickson DS (1972) Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative centrifuge. Clin Chem 18: 499-502
6. Goldstein JL, Hobbs HH, Brown MS (1995) Familial hypercholesterolemia. In: Scriver CR, Beaudet AL, Sly WS, Valle D (eds) The metabolic basis of inherited disease, 7th edn. McGraw-Hill, New York, pp 1981-2030
7. Havel RJ, Hunninghake DB, Illingworth DR, Lees RS, Stein EA, Tobert JA, Bacon SR, Bolognese JA, Frost PH, Lamkin GE (1987) Lovastatin (mevinolin) in the treatment of heterozygous familial hypercholesterolemia: a multi-center study. Ann Intern Med 107: 609-615
8. Knipscheer HC, Boelen CA, Kastelein JJP, Van Diermen DE, Groenemeijer BE, Van Den Ende A, Bullet HR, Bakker HD (1996) Short-term efficacy and safety of Pravastatin in 72 children with familial hypercholesterolemia. Pediatr Res 39: 867-871
9. Lambert M, Lupien PJ, Gagné C, Levy E, Blaichman S, Langlois S, Hayden M, Rose V, Clarke JT, Wolfe BM, Clarson C, Parsons H, Stephure DK, Potvin D, Lambert J (1996) Treatment of familial hypercholesterolemia in children and adolescents: effect of Lovastatin. Pediatrics 97: 619-628
10. McGill HC, Geer JC, Strong JP (1983) The natural history of human atherosclerotic lesions. In: Sander M, Bourne G (eds) Atherosclerosis and its origin. Academic Press, New York, pp 38-65
11. McGill HC, McMahan A, Zieske A, Tracy RE, Malcolm GT, Herderick EE, Strong JP (2000) Association of coronary risk factors with microscopic qualities of coronary atherosclerosis in youth. Circulation 102: 374-379
12. Pedersen TR, Olsen AG, Faergeman O, Kjekshus J, Wedel H, Berg K, Wilhelmsen L, Haghfelt T, Thorgeirssen G, Pyorala K, Miettinen T, Christophersen B, Tobert JA, Musliner TA, Cook TJ (1998) Lipoprotein changes and reduction in the incidence of major coronary heart disease events in the Scandinavian Simvastatin Survival Study (4S). Circulation 97: 1453-1460
13. Report of the expert panel on blood cholesterol levels in children and adolescents (1992) National Cholesterol Education Program. Pediatrics 89: 525-584
14. Scandinavian Simvastatin Survival Study Group (1994) Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: the Scandinavian Simvastatin Survival Study (4S) Lancet 344: 1383-1389
15. Sheperd J, Cobbe SM, Ford I (1995) Prevention of coronary heart disease with pravastatin in men with hypercholesterolemia. N Engl J Med 333: 1301-1307
16. Slack J (1969) Risks of ischaemic heart disease in familial hyperlipoproteinemic states. Lancet 2: 1380-1382
17. Stein EA (1989) Treatment of familial hypercholesterolemia with drugs in children. Arteriosclerosis 9[Suppl 1]: 145-151
18. Stein EA, Illingworth DR, Kwiterovich PO, Liacouras CA, Siimes MA, Jacobson MS, Brewster TG, Hopkins P, Davidson M, Graham K, Arensman F, Knopp RH, DuJovne C, Williams CL, Isaacsohn JL, Jacobsen CA, Laskarzewski PM, Ames S, Gormley GJ (1999) Efficacy and safety of lovastatin in adolescent males with heterozygous familial hypercholesterolemia. JAMA 281: 137-144
19. Stone MJ, Levy RI, Fredrickson DS, Verter J (1974) Coronary artery disease in 116 kindred with familial type II hyperlipoproteinemia. Circulation 49: 476-488
20. West RJ (1985) Problems of long-term treatment in children with familial hypercholesterolemia. Prog Clin Biol Res 188: 209-211